RxDoctor Payments DataLook up a doctor →

Fred Umeh, MD

Critical Care Medicine · Kissimmee, FLNPI 1114995842

Payments from drug & device makers

$682,002in general payments, 2019–2025

Across 1,410 payments — averaging $483.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$291K
  • AstraZeneca$190K
  • Insmed, Inc.$139K
  • Astrazeneca AB$30K
  • United Therapeutics Corporation$10K
  • Boehringer Ingelheim$4K
  • plus $17K from 49 others
$1,282in research payments, 2019–2025

Across 4 payments — averaging $320.62 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Insmed, Inc.$1K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
GSK397$291,460
AstraZeneca311$190,422
Insmed, Inc.162$138,877
Astrazeneca AB4$30,074
United Therapeutics Corporation27$10,214
Boehringer Ingelheim128$3,762
AbbVie10$3,188
Viiv Healthcare Company1$1,600
Sanofi44$1,542
Grifols USA, LLC45$1,345
Actelion Pharmaceuticals US, Inc.37$1,196
Regeneron Healthcare Solutions, Inc.31$970
Philips North America LLC32$870
Jazz Pharmaceuticals Inc.14$734
Gilead4$444
Harmony Biosciences LLC9$434
Takeda Pharmaceuticals U.S.A., Inc.19$429
Bayer11$420
Amgen7$359
Genentech USA, Inc.15$356
Paratek Pharmaceuticals, Inc.6$315
Johnson & Johnson(2 entities)6$299
Mylan Specialty L.p.13$261
Novartis14$248
Vapotherm Inc3$202
ZOLL Respicardia, Inc.1$170
Teva Pharmaceuticals USA, Inc.9$148
E.r. Squibb & Sons, L.L.C.4$148
Pulmonx Corporation1$141
La Jolla Pharmaceutical Company1$129
Idorsia Pharmaceuticals US Inc2$125
Vertex1$120
Sun Pharmaceutical Industries Inc.1$118
Avadel CNS Pharmaceuticals, LLC1$115
Axsome Therapeutics, Inc.2$114
Verona Pharma, Inc.4$81
Viatris Specialty LLC3$76
Baxter Healthcare3$73
Vifor Pharma, Inc.3$71
Electromed, Inc.5$68
Merck2$43
Sandoz2$35
Mallinckrodt Hospital Products Inc.1$24
Inspire Medical Systems, Inc.1$21
Portola Pharmaceuticals, LLC1$19
Fisher & Paykel Healthcare Inc1$19
ANI Pharmaceuticals, Inc.1$17
Inogen, Inc.3$17
Eisai Inc.1$15
Circassia Inc.1$14
Boston Scientific1$13
Shire North American Group Inc1$13
Nabriva Therapeutics, PLC1$13
Pinnacle Biologics, Inc1$12
Phadia US Inc.1$11

How this compares

$682,002 in reported general payments places this provider in the 95th percentile of 618 critical care medicine providers in Florida.

See all critical care medicine providers in Florida →

Medicare billing

Part B allowed, 2024
$548,291
Medicare patients
752
Services billed
11,900

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other critical care medicine in Kissimmee

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →